Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Prostate cancer and the Mevalonate pathway

  • Guerrero-Ochoa, Patricia
  • Rodríguez-Zapater, Sergio
  • Anel, Alberto
  • Esteban, Luis Mariano
  • Camón-Fernández, Alejandro
  • Espilez-Ortiz, Raquel
  • Gil-Sanz, María Jesús
  • Borque-Fernando, Ángel
Antineoplastic therapies for prostate cancer (PCa) have traditionally centered around the androgen receptor (AR) pathway, which has demonstrated a significant role in oncogenesis. Nevertheless, it is becoming progressively apparent that therapeutic strategies must diversify their focus due to the emergence of resistance mechanisms that the tumor employs when subjected to monomolecular treatments. This review illustrates how the dysregulation of the lipid metabolic pathway constitutes a survival strategy adopted by tumors to evade eradication efforts. Integrating this aspect into oncological management could prove valuable in combating PCa.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The utility of fetal heart rate deceleration's descending slope in searching for a non-National Institute of Child Health and Human Development parameter for the detection of fetal acidosis

  • Castan Larraz, Berta
  • Esteban, Luis Mariano
  • Castán Mateo, Sergio
  • Chóliz Ezquerro, Marta
  • Calvo Torres, Javier
  • Esteban-Escaño, Javier
  • Rodríguez Solanilla, Belén
  • Cisneros Gimeno, Ana
  • Savirón-Cornudella, Ricardo
AbstractObjectiveTo identify new parameters predicting fetal acidemia.MethodsA retrospective case–control study in a cohort of deliveries from a tertiary referral hospital‐based cohort deliveries in Zaragoza, Spain between 2018 and 2021 was performed. To predict fetal acidemia, the NICHD categorizations and non‐NICHD parameters were analyzed in the electronic fetal monitoring (EFM). Those included total reperfusion time, total deceleration area and the slope of the descending limb of the fetal heart rate of the last deceleration curve. The accuracy of the parameters was evaluated using the specificity for (80%, 85%, 90%, 95%) sensitivity and the area under the receiver operating characteristic curve (AUC).ResultsA total of 10 362 deliveries were reviewed, with 224 cases and 278 controls included in the study. The NICHD categorizations showed reasonable discriminatory ability (AUC = 0.727). The non‐NICHD parameters measured during the 30‐min fetal monitoring, total deceleration area (AUC = 0.807, 95% CI: 0.770, 0.845) and total reperfusion time (AUC = 0.750, 95% CI: 0.707, 0.792), exhibited higher discriminatory ability. The slope of the descending limb of the fetal heart rate of the last deceleration curve had the best AUC value (0.853, 95% CI: 0.816, 0.889). The combination of total deceleration area or total reperfusion time with the slope demonstrated high discriminatory ability (AUC = 0.908, 95% CI: 0.882, 0.933; specificities of 71.6% and 72.7% for a sensitivity of 90%).ConclusionsThe slope of the descending limb of the fetal heart rate of the last deceleration curve is the strongest predictor of fetal acidosis, but its combination with the total reperfusion time shows better clinical utility.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Diagnosis of cardiotocographic sinusoidal patterns by spectral analyses

  • Savirón-Cornudella, Ricardo
  • Laliena Bielsa, Antonio
  • Esteban-Escaño, Javier
  • Calvo Torres, Javier
  • Chóliz Ezquerro, Marta
  • Castán Larraz, Berta
  • Díaz de Terán Martínez-Berganza, Elisa
  • Rodríguez Castaño, María José
  • Álvaro Navidad, Miguel
  • Andeyro García, Mercedes
  • Whyte Orozco, Jaime
  • Castán Mateo, Sergio
  • Esteban, Luis Mariano
Background The sinusoidal pattern in cardiotocographic (CTG) monitoring shows a sinus-shaped signal longer than 30 min without short-term variability. It is commonly linked to fetal morbidity, particularly severe fetal anemia. Pseudosinusoidal patterns resemble sinusoidal patterns but without adverse fetal outcomes. This study aims to characterise sinusoidal and pseudosinusoidal patterns using spectral analysis. Methods A multicenter study case-control was conducted between January 2012 and February 2023. Maternal characteristics, perinatal data, and CTG parameters through spectral analysis were examined. The spectrum of the electrocardiographic signal was calculated, and the proportion of energy (PE), short- and long-term variability, amplitude, and the differences between sinusoidal, pseudosinusoidal, and control groups were compared. A predictive model for signal type was built using a classification tree. Results 60 CTG records were collected, including 38 controls. Of the 13 sinusoidal patterns detected, all exhibited a sinusoidal pattern with a PE ratio > 0.3, 9 of them (69 %) had a PE ratio > 0.5, and 4 (31 %) were in the range of 0.3–0.5. Among the 9 cases diagnosed as pseudosinusoidal, all had a sinusoidal pattern with a PE within the range of 0.3–0.5. Every control exhibited a PE < 0.3, except for one case. Short-term variability demonstrated limited discriminatory capability, while long-term variability showed a strong discriminatory capacity. For the classification tree, accuracy diagnosis was 92.3 %, 88.8 %, and 97.3 % for the sinusoidal, pseudosinusoidal, and control groups, respectively. Conclusion Computerised spectral analysis and the variable PE within the frequency range of 1.8–3.5 are reliable parameters to discriminate sinusoidal patterns.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques

  • Esteban, Luis Mariano
  • Borque-Fernando, Ángel
  • Escorihuela, Maria Etelvina
  • Esteban-Escaño, Javier
  • Abascal, Jose María
  • Servian, Pol
  • Morote, Juan
In prostate cancer (PCa), risk calculators have been proposed, relying on clinical parameters and magnetic resonance imaging (MRI) enable early prediction of clinically significant cancer (CsPCa). The prostate imaging–reporting and data system (PI-RADS) is combined with clinical variables predominantly based on logistic regression models. This study explores modeling using regularization techniques such as ridge regression, LASSO, elastic net, classification tree, tree ensemble models like random forest or XGBoost, and neural networks to predict CsPCa in a dataset of 4799 patients in Catalonia (Spain). An 80–20% split was employed for training and validation. We used predictor variables such as age, prostate-specific antigen (PSA), prostate volume, PSA density (PSAD), digital rectal exam (DRE) findings, family history of PCa, a previous negative biopsy, and PI-RADS categories. When considering a sensitivity of 0.9, in the validation set, the XGBoost model outperforms others with a specificity of 0.640, followed closely by random forest (0.638), neural network (0.634), and logistic regression (0.620). In terms of clinical utility, for a 10% missclassification of CsPCa, XGBoost can avoid 41.77% of unnecessary biopsies, followed closely by random forest (41.67%) and neural networks (41.46%), while logistic regression has a lower rate of 40.62%. Using SHAP values for model explainability, PI-RADS emerges as the most influential risk factor, particularly for individuals with PI-RADS 4 and 5. Additionally, a positive digital rectal examination (DRE) or family history of prostate cancer proves highly influential for certain individuals, while a previous negative biopsy serves as a protective factor for others.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results

  • Rubio-Briones, J.
  • Borque-Fernando, A.
  • Esteban Escaño, L.M.
  • Wong, A.
  • Guijarro Cascales, A.
  • Gómez Gómez, E.
  • Gil Fabra, J.M.
  • Sanguedolce, F.
  • Gomez-Veiga, F.
  • López González, P.A.
  • Plata Bello, A.
  • Rodríguez García, N.
  • Montesino Semper, M.
  • Suárez Novo, J.F.
  • Hajianfar, R.
  • Fumadó Ciutat, L.l.
  • González Alfaro, A.
  • Duarte Ojeda, J.M.
  • Bono Ariño, A.
  • Quicios Dorado, C.
  • Loizaga Iriarte, A.
  • García Fadrique, G.
  • Giménez Bachs, J.M.
  • García Barreras, S.
  • Pallas Costa, Y.
  • Vilaseca Cabo, A.
  • Rodrigo Aliaga, M.
  • Campanario Pérez, F.
  • Servián, P.
  • Campá Bortoló, J. M.
  • Soto Delgado, M.
  • Rodríguez de Ledesma, J.M.
  • Sánchez Rodríguez, C.
  • Chantada Abal, V.
  • Hernández Martínez, Y.E.
  • Herrera Imbroda, B.
  • Dolezal, P.
  • Gual Frau, J.
  • Medrano Llorente, P.
  • Moreno Jiménez, J.
  • Serrano Uribe, J.S.
  • Congregado Ruiz, C.B.
  • Reyes, A.
  • Fernández Aparicio, T.
  • García Rodríguez, J.
  • Cuadras Solé, M.
  • García Seguí, A.
  • Pacheco Bru, J.J.
  • Mayor de Castro, J.
  • Mira Moreno, A.
  • Molina Suárez, J.L.
ABSTRACTPatients and MethodsIn this multicenter longitudinal study, data from the Spanish Register in AS (AEU‐PIEM/2014/0001) were reviewed. The study focused on a cohort of AS patients registered between 2014 and 2019, featuring open inclusion criteria and diverse follow‐up strategies.ResultsA total of 3315 AS patients were recruited, with 2881 and 434 categorized into the low and intermediate risk groups based on NCCN grouping at inclusion. The median age was 67 years, and only 11% underwent diagnostic biopsy guided by MRI. The median time between follow‐up visits was 6.03 months. Over a median follow‐up of 62 months (Q1–3: 43.78–85.58), 37% remained in AS, while 8% transitioned to watchful waiting due to aging or intercurrent disease. Death occurred in 199 (6%) of patients, with 3 due to prostate cancer progression and 196 attributed to other causes. At 2 and 5 years, pathological progression‐free survival, metastasis‐free survival, and active treatment‐free survival were 68% and 51%, 99% and 99%, and 70% and 50%, respectively.ConclusionsMidterm oncological outcomes of AS in Spain align with major international series. We denote underuse of guideline recommendations such as use of MRI or TP Bx for initial PCa characterization. Collaborative efforts are crucial in the search for algorithms, new imaging, or biomarkers to refine indications and transition to active treatments.Trial RegistrationClinicalTrials.gov identifier: NCT02865330